Effectiveness of Guideline for Dissemination and Education in Psychiatric Treatment: Phase 2

Effectiveness of Guideline for Dissemination and Education in Psychiatric Treatment: Phase 2 - EGUIDE study Phase 2

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000061038

Enrollment

100

Registered

2026-03-24

Start date

2025-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychiatrists treating patients with schizophrenia and depression

Interventions

Educational lectures of Japanese treatment guidelines for schizophrenia and depression

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Psychiatrists treating patients with schizophrenia and depression

Exclusion criteria

Exclusion criteria: non-psychiatrist

Design outcomes

Primary

Measure	Time frame
Scale for comprehension of guidelines schizophrenia and depression, prescription	—

Countries

Japan

Contacts

Public ContactNorio Yasui-Furukori

Dokkyo Medical University School of Medicine Department of Psychiatry

furukori@dokkyomed.ac.jp0282-86-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026